Mammo July 2026

Imagion Biosystems and Siemens Healthineers Extend Collaboration

Imagion Biosystems has extended its collaboration with Siemens Healthineers to support the Phase 2 clinical trial of the MagSense imaging agent for HER2-positive breast cancer.

AI Mammogram Risk Scores May Improve Long-Term Breast Cancer Risk Assessment

Researchers have found that AI-derived breast cancer risk scores from screening mammograms change over time in women who develop breast cancer while remaining stable in cancer-free women.